X-102653934-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001184727.2(GPRASP1):āc.21G>Cā(p.Glu7Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,208,584 control chromosomes in the GnomAD database, including 1 homozygotes. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001184727.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000978 AC: 11AN: 112503Hom.: 1 Cov.: 23 AF XY: 0.000115 AC XY: 4AN XY: 34653
GnomAD3 exomes AF: 0.00000551 AC: 1AN: 181433Hom.: 0 AF XY: 0.0000151 AC XY: 1AN XY: 66011
GnomAD4 exome AF: 0.00000365 AC: 4AN: 1096026Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 361498
GnomAD4 genome AF: 0.0000977 AC: 11AN: 112558Hom.: 1 Cov.: 23 AF XY: 0.000115 AC XY: 4AN XY: 34718
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 26, 2024 | The c.21G>C (p.E7D) alteration is located in exon 6 (coding exon 1) of the GPRASP1 gene. This alteration results from a G to C substitution at nucleotide position 21, causing the glutamic acid (E) at amino acid position 7 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at